DSM’s new coating provides an osteoconductive scaffold at the point of repair, unlike other osteoconductive coatings. It has both patents granted and patents pending.
“This is a major step for Riverpoint in providing superior solutions and rapidly innovating high-quality medical devices to improve patient outcomes. Our exclusive OC coating technology is a first of its kind in the field of bone fixation and healing,” Doug King, CEO of Riverpoint Medical, said in a March 7 press release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
